Antiaging Qntum LGN A lost $0.03 per diluted share in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to a loss of $0.03 per diluted share. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters Antiaging Qntum LGN A has filed alongside them.
FY2026 annual
EPS (Diluted)-$0.03
YoYn/m
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2027, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
AAQL EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Antiaging Qntum LGN A lost $0.03 per diluted share in fiscal year 2026.
Antiaging Qntum LGN A (AAQL) reported a loss of $0.02 per diluted share in fiscal year 2025 and a loss of $0.03 per diluted share in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Antiaging Qntum LGN A (AAQL) reported a loss of $0.03 per diluted share over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
Antiaging Qntum LGN A (AAQL) reported -$0.01 in diluted earnings per share in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Antiaging Qntum LGN A (AAQL) reported on that line in every period on record.
